title: Disengaging insulin from corticosterone: roles of each on energy intake and disposition.
abstract: Corticosterone and insulin play complex roles in the amount and composition of calories ingested, and the utilization and deposition of this energy. Understanding the interplay of these two hormones is complicated because increasing concentrations of corticosterone dose-dependently increase circulating insulin levels. We addressed individual contributions of each hormone by controlling, at steady-state levels, corticosterone (by adrenalectomy and exogenous replacement) and insulin (by streptozotocin-induced destruction of pancreatic beta-cells and exogenous replacement) across a spectrum of concentrations in rats, creating 8 hormonal combinations. For 5 days after surgery, all rats received chow. At day 5, they were subdivided into those that continued to receive chow and those that had a choice between chow, lard, and 32% sucrose for a further 5 days. During the choice/chow period, total calories ingested were stimulated by corticosterone and choice diet, and subject to a corticosterone-insulin interaction. Sucrose, but not lard, intake was stimulated by insulin. Body weight was increased by insulin, decreased by high corticosterone, and unaffected by diet. White adipose tissue depot weights were stimulated by insulin, corticosterone, and diet. Plasma triglycerides, free fatty acids, total ketone bodies, glucose, and glycerol were all significantly increased by corticosterone and the choice diet but inhibited by insulin. In contrast, plasma leptin was only increased by insulin and diet, plasma glucagon and liver glycogen was only affected by insulin and liver triglycerides, and arcuate nucleus proopiomelanocortin mRNA was only influenced by diet. Collectively, these data show that corticosterone and insulin determine the intake, form, and compartmentalization of energy both independently and interactively.
authors.affiliation: Department of Physiology,University of California San Francisco, San Francisco, CA 94143, USA.
authors.forename: James P
authors.initials: JP
authors.lastname: Warne
authors.forename: Susan F
authors.initials: SF
authors.lastname: Akana
authors.forename: Abigail B
authors.initials: AB
authors.lastname: Ginsberg
authors.forename: Hart F
authors.initials: HF
authors.lastname: Horneman
authors.forename: Norman C
authors.initials: NC
authors.lastname: Pecoraro
authors.forename: Mary F
authors.initials: MF
authors.lastname: Dallman
mesh_terms: D000315:Adrenalectomy; D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000378:metabolism; D001835:Body Weight / Q000502:physiology; D003345:Corticosterone / Q000502:physiology*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D004195:Disease Models, Animal; D002149:Energy Intake / Q000502:physiology*; D004734:Energy Metabolism / Q000502:physiology*; D006003:Glycogen / Q000378:metabolism; D007328:Insulin / Q000502:physiology*; D020738:Leptin / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D009478:Neuropeptide Y / Q000378:metabolism; D011333:Pro-Opiomelanocortin / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013311:Streptozocin; D014280:Triglycerides / Q000378:metabolism
chemical_list: D007328:Insulin; D020738:Leptin; D009478:Neuropeptide Y; D014280:Triglycerides; D013311:Streptozocin; D011333:Pro-Opiomelanocortin; D006003:Glycogen; D003345:Corticosterone